Johnson Jeh C. 4

What Happened Jeh C. Johnson, a director of MetLife, received 61 shares on 2026-06-09 at an imputed price of $85.57 per share, totaling roughly $5,220. The transaction is recorded as an award/acquisition (A) and reflects an imputed reinvestment of dividends rather than an open-market purchase.

Key Details

• Transaction date and price: 2026-06-09 at $85.57 per share (total ≈ $5,220).
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnote: Imputed reinvestment of dividends on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors (deferred shares are payable shares the director has elected to defer).
• Filing timeliness: Form filed 2026-06-11 for the 2026-06-09 transaction (appears timely per SEC Form 4 rules).

Context This was a routine dividend reinvestment into deferred director compensation, not an open-market buy or sale. Such awards reflect plan mechanics (reinvesting dividends into deferred share balances) and do not necessarily indicate director trading sentiment.